Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Income from Continuing Operations (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Income from Continuing Operations for 6 consecutive years, with 6745000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations fell 989.66% year-over-year to 6745000.0, compared with a TTM value of 56697000.0 through Dec 2025, down 1.12%, and an annual FY2025 reading of 56697000.0, down 1.12% over the prior year.
  • Income from Continuing Operations was 6745000.0 for Q4 2025 at Treace Medical Concepts, up from 16380000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 619000.0 in Q4 2024 and bottomed at 21318000.0 in Q2 2024.
  • Average Income from Continuing Operations over 5 years is 11053550.0, with a median of 12227000.0 recorded in 2022.
  • The sharpest move saw Income from Continuing Operations surged 90.29% in 2024, then crashed 989.66% in 2025.
  • Year by year, Income from Continuing Operations stood at 6620000.0 in 2021, then skyrocketed by 39.44% to 4009000.0 in 2022, then tumbled by 59.07% to 6377000.0 in 2023, then soared by 90.29% to 619000.0 in 2024, then plummeted by 989.66% to 6745000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for TMCI at 6745000.0 in Q4 2025, 16380000.0 in Q3 2025, and 17520000.0 in Q2 2025.